PRO DEX INC (PDEX)
Health Care · surgical instruments and medical power tools · NASDAQ
Pro-Dex manufactures precision surgical and dental power instruments used in operating rooms and dental practices across the healthcare sector.
What PRO DEX INC does
Pro-Dex, Inc. designs, develops, and manufactures specialized medical devices and precision surgical instruments for the medical device industry. The company provides complex engineering and manufacturing services, including the production of high-precision motorized surgical handpieces and related control systems. Pro-Dex operates primarily as a contract manufacturer and engineering partner for medical original equipment manufacturers (OEMs).
Themes: surgical instruments, dental equipment, orthopedic instruments, medical device manufacturing
Fundamentals
- Price$65.67 as of 2026-08-21 close
- Market cap$210M as of 2026-08-21
- 1-year return+36.8% 2025-08-21 close $48.00 → 2026-08-21 close $65.67
- P/E17.93 as of 2026-08-24
- Net margin+16.1% as of 2026-08-24
- Gross margin+27.8% as of 2026-08-24
- ROE+29.1% as of 2026-08-24
- Debt / equity0.41 as of 2026-08-24
- Revenue growth (YoY)+16.4% as of 2026-08-24
- Revenue CAGR (3y)+16.6% SEC XBRL
- Beta0.07 as of 2026-08-24
- Last reported earnings2026-04-30 SEC EDGAR Form 8-K (Item 2.02)
How PDEX compares in its sector
- price-to-earnings ratiomiddle range 203 covered Health Care peers, as of 2026-08-24
- net profit margintop 25% 504 covered Health Care peers, as of 2026-08-24
- operating margintop 25% 504 covered Health Care peers, as of 2026-08-24
- gross marginbottom 25% 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 10% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How PRO DEX INC looks technically
PRO DEX INC (PDEX) is trading 32.2% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 132 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 14 trading days ago. Trading volume is unusually light — only about 35% of its 30-day average.
Trend
7
| Distance from the 200-day | it is trading 32.2% above its 200-day average, the long-term trend line — a longer-term uptrend | +32.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $61.79 | $61.79 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $49.69 | $49.69 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 17 calendar days ago — the swings before that are what the structure reading is measured on | 17 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 132 trading days ago — a "golden cross", a bullish long-term signal | 132 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend) | 17.2 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30) | 56.1 |
|---|---|---|
| Position in its 14-day range | it is trading around the middle of its 14-day range ($61.74 to $69.86) — its "stochastic" reading is 48 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 48.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 16 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $69.86 | $69.86 |
|---|---|---|
| From the 52-week high | it is 6.0% below its 52-week high (its highest price of the past year) | -6.0% |
| Above the 52-week low | it is 179.8% above its 52-week low (its lowest price of the past year) | +179.8% |
| Below the 52-week high | it is 6.0% below its highest point of the past year | 6.0% |
| Since a 20-day breakout | it made a new 20-day high about 14 trading days ago | 14 sessions |
| Since a 55-day breakout | it made a new 55-day high about 14 trading days ago | 14 sessions |
| All-time high | its highest closing price on record is $70.26 (set on 2025-04-24) | $70.26 |
| Given back of the 52-week move | over the past year its closes ranged ($23.91 to $68.44), and it has given back only a small part of its rise from last year’s low — 6% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $39.50 to $40.92. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 6.2% |
| From the all-time high | it is 6.5% below its all-time high | -6.5% |
| Nearest price level | it is trading 4.9% below a resistance level at $68.89 — a price it turned at twice since 2026-06-02, most recently on 2026-08-04. Since 2024-08-21 it has 16 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +4.9% |
| All-time low | its lowest closing price on record is $0.8105 (set on 2009-03-03) | $0.8105 |
| Above the all-time low | it is 8002.3% above its all-time low | +8,002% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 74% of it) | 74th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $3.35 between its high and its low — about 5.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $3.35 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $55.30 and $72.83 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $55.30 – $64.07 – $72.83 |
| Typical daily range (% of price) | its price moves about 5.1% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 5.1% |
| Stretch from the 200-day average | it is trading 4.8 daily ranges above its 200-day average price (32.2% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 4.8 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is unusually light — only about 35% of its 30-day average | 0.35× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.4% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.4% |
|---|---|---|
| Open gap | it gapped 3.5% above the previous close 14 sessions ago and has not traded back through the level it left behind at 58.57 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +3.5% |
| Gap filled | a 2.3% gap down opened on 2026-08-17 has been "filled" 4 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 4 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -1.9% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 14.9 percentage points (the stock gained 17.2% while the market gained 2.3%) | +14.9% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 1.8 percentage points (the stock gained 4.9% while the market gained 3.1%) | +1.8% |
| vs market, 6 months | over the past 6 months this stock beat the market by 55.1 percentage points (the stock gained 66.2% while the market gained 11.1%) | +55.1% |
| vs market, 12 months | over the past 12 months this stock beat the market by 16.3 percentage points (the stock gained 36.8% while the market gained 20.5%) | +16.3% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bearish state — these describe past price behaviour, not a forecast | 0 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 8.3% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 6.8% of the share price. | +8.3% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 15% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $57.15 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | +14.9% |
|---|---|---|
| Vs the average paid since it last reported | the price is 6% above the average price paid since it last reported on 2026-04-30 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $61.74 — a volume-weighted average of daily closes over 77 sessions, not a true tick-by-tick VWAP. | +6.4% |
Price levels it has turned at before
PDEX last closed at $65.67 on 2026-08-21. Since 2024-08-21 it has turned at 16 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $68.89 | Resistance | 4.9% above the last close | turned there twice · 2026-06-02 to 2026-08-04 |
| $59.33 | Support | 9.7% below the last close | turned there twice · 2025-01-06 to 2026-06-11 |
| $55.25 | Support | 15.9% below the last close | turned there three times · 2024-12-06 to 2026-06-29 |
| $52.95 | Support | 19.4% below the last close | turned there twice · 2026-04-02 to 2026-07-22 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · trendless / choppy (low ADX) · beating the market · Trading above the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · breakout · volume and relative volume
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$70.00 range $70.00 – $70.00
Analyst estimates, as of 2026-08-23. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Key risks (from latest filing)
["Dependence on surgical and dental procedures for revenue, which can be impacted by healthcare spending levels and procedural volume fluctuations","Inventory management challenges as evidenced by working capital variations in recent periods","Acquisition integration risk, as the company made material acquisitions (notably APM) that require successful integration and realization of expected synergies"]
What changed in the latest 10-Q
AI-assisted comparison of PDEX's 10-Q filed 2026-04-30 against the prior one filed 2026-01-29.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-30) specifies comparison periods as 'three-month and nine-month periods ended March 31, 2026 and 2025' versus older filing's 'three-month and six-month periods ended December 31, 2025 and 2024'
- Newer filing adds risk factor: 'our ability to integrate and effectively operate Advanced Precision Machining, LLC ("APM")'
- Newer filing adds risk factor: 'the impact of tariffs on the cost of our raw materials and purchased components'
- Newer filing states: 'During the third quarter of fiscal 2026, we completed the acquisition of APM, one of our significant suppliers'
- Newer filing mentions APM's location: 'a second machine shop located in Costa Mesa, California'
- Newer filing states APM provides 'machining to other customers primarily in the defense and aerospace industries'
- Newer filing lists two Internet addresses: 'www.pro-dex.com and www.advanced-precision.com'
- Newer filing adds reference to 'www.sec.gov/edgar/searchedgar/companysearch.html' for SEC filings
- Removed:
- Older filing (2026-01-29) included risk factor: 'our ability to optimize our operations at our Franklin facility'
- Older filing stated: 'Additionally, we provide engineering, quality, and regulatory consulting services to our customers'
- Older filing stated rotary air motors 'comprise a de minimis portion of our business'
- Older filing stated: 'We are actively pursuing the acquisition of one of our significant suppliers to help meet the increased demand'
- Older filing included product discussion: 'our latest Pro-Dex branded product, the Helios driver for CMF applications, featuring our adaptive torque-limiting software, is expected to be released for production later this fiscal year'
- Older filing contained statement: 'While we have had interest in this product, there is no guarantee that our existing customers or new customers will purchase this new driver'
- Older filing listed only 'www.pro-dex.com' as Internet address (singular)
- Reworded:
- Older filing stated 'which appeal to our customers' changed to 'which appeal to our customers' in newer (minor punctuation change from semicolon to period structure)
- Newer filing: 'precision machined parts and assemblies for the aerospace and defense industries through our APM subsidiary' - this is expanded detail replacing older filing's mention of rotary air motors as de minimis
- Older filing reference to 'three and six months ended December 31, 2025' changed to 'three and nine months ended March 31, 2026' in Critical Accounting Estimates section
- Notes:
- Newer filing text appears truncated at end ('Our patented adaptive torque-limiting softw'), preventing full comparison of final sections
- Older filing text also appears truncated ('In November 2020, we purchased an approximate 25,000 square foot indust'), preventing full comparison
- The filings cover different fiscal periods (Q2 FY2026 vs Q3 FY2026), which naturally accounts for some content changes regarding business developments
Risk Factors
- Added:
- Added goodwill of $6,525 thousand as of March 31, 2026 in non-current assets (newer filing, filed 2026-04-30)
- Added 'Purchase of APM, net of cash acquired' investing activity of $6,495 thousand for nine months ended March 31, 2026 (newer filing, filed 2026-04-30)
- Added 'Promissory note issued in conjunction with APM acquisition' non-cash activity of $2,000 thousand (newer filing, filed 2026-04-30)
- Added 'Amortization of loan fees, net' of $8 thousand in operating activities adjustments for nine months ended March 31, 2026 (newer filing, filed 2026-04-30)
- Removed:
- Removed disclosure of allowance for expected credit losses in accounts receivable description (was shown in older filing, absent in newer filing)
- Reworded:
- Balance sheet header changed from 'PRO-DEX, INC. AND SUBSIDIARY' (older filing, filed 2026-01-29) to 'PRO-DEX, INC. AND SUBSIDIARIES' (newer filing, filed 2026-04-30)
- Income statement header changed from 'STATEMENTS OF OPERATIONS' (older filing, filed 2026-01-29) to 'INCOME STATEMENTS' (newer filing, filed 2026-04-30)
- Common stock description changed from 'Common stock; no par value' (older filing, filed 2026-01-29) to 'Common shares; no par value' (newer filing, filed 2026-04-30)
- Line item changed from 'Gain (loss) on marketable equity investments, net' in older filing (filed 2026-01-29) to 'Gain on equity investments, net' in newer filing (filed 2026-04-30)
- Line item changed from 'Non-cash lease recovery' in older filing (filed 2026-01-29) to 'Non-cash straight-line lease amortization' in newer filing (filed 2026-04-30)
- Notes:
- The two filings cover different reporting periods: older filing is for six and three months ended December 31, 2025; newer filing is for nine and three months ended March 31, 2026
- Balance sheet comparisons use different prior-year dates (June 30, 2025 in both) but different current period dates (December 31, 2025 vs. March 31, 2026)
- Financial statement figures are not directly comparable due to different fiscal periods covered
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days0 buys · 7 sells ($673393) — 2 selling insiders
Most recent open-market transaction: 2026-05-22. As of 2026-08-25.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about PDEX's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding PDEX as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 194,857
- Reported value $9,571,377
reported quarterly holdings change (2025-12-31 → 2026-03-31): 1 new, 1 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
PDEX had 170,708 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
PDEX had 5.35% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 1.71 days to cover at the same settlement.
- Reported short interest (shares) 170,708
- Short interest (% of shares outstanding) 5.35%
- Prior settlement (shares) 157,066
- Reported change 8.69%
- Days to cover (reported) 1.71
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare PDEX vs…
Frequently asked questions
What does PRO DEX INC (PDEX) do?
Pro-Dex, Inc. designs, develops, and manufactures specialized medical devices and precision surgical instruments for the medical device industry. The company provides complex engineering and manufacturing services, including the production of high-precision motorized surgical handpieces and related control systems. Pro-Dex operates primarily as a contract manufacturer and engineering partner for medical original equipment manufacturers (OEMs).
What sector is PRO DEX INC (PDEX) in?
PRO DEX INC (PDEX) is classified in the Health Care sector. Its industry is surgical instruments and medical power tools. It trades on NASDAQ.
Who are PRO DEX INC's (PDEX) competitors?
Notable peers of PRO DEX INC (PDEX) include Stryker Corporation, Zimmer Biomet, Smith & Nephew, CONMED Corporation and Arthrex. This peer set is informational only — not financial advice.
Is PRO DEX INC (PDEX) overbought or oversold right now?
PRO DEX INC (PDEX) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 56, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on PDEX come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.